The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam



Status:Archived
Conditions:Osteoporosis, Postmenopausal Syndrome
Therapuetic Areas:Endocrinology, Rheumatology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:July 2011

Use our guide to learn which trials are right for you!

The Effects of Denosumab on the Pharmacokinetics (PK) of Midazolam, a Cytochrome P450 3A4/P-gp (CYP3A4) Substrate, in Postmenopausal Osteoporotic Women


This is a multi-center, open-label, drug-drug interaction study in postmenopausal women with
osteoporosis.



We found this trial at
2
sites
?
mi
from
San Diego, CA
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials